Stults; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stults; Jeffrey.The latest application filed is for "process for the manufacturing of medicaments".

Company Profile

3.8.12

Stults; Jeffrey - Half Moon Bay CA
Stults; Jeffrey - South San Francisco CA
Stults; Jeffrey - El Granada CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the manufacturing of medicaments Grant 11,098,028 - Lin , et al. August 24, 2	2021-08-24
Process for the manufacturing of medicaments Grant 11,066,389 - Lin , et al. July 20, 2	2021-07-20
Process For The Manufacturing Of Medicaments App 20200190061 - LIN; JINGUANG ; et al.	2020-06-18
Process for the manufacturing of medicaments Grant 10,611,753 - Lin , et al.	2020-04-07
Process For The Manufacturing Of Medicaments App 20190367484 - LIN; JINGUANG ; et al.	2019-12-05
Crystalline Forms Of A Pyrrolopyridine Compound App 20180282324 - Stults; Jeffrey ; et al.	2018-10-04
Process For The Manufacturing Of Medicaments App 20180134685 - Lin; Jinguang ; et al.	2018-05-17
Process For The Manufacturing Of Medicaments App 20170022183 - Lin; Jinguang ; et al.	2017-01-26
Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof Grant 9,505,725 - Chakravarty , et al. November 29, 2	2016-11-29
Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof Grant 9,481,690 - Stults , et al. November 1, 2	2016-11-01
Crystalline Forms Of A Pyrrolopyridine Compound App 20160251350 - Stults; Jeffrey ; et al.	2016-09-01
Polymorphs Of 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]i- Midazo[1,2-d][1,4]oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide, Methods Of Production, And Pharmaceutical Uses Thereof App 20160222027 - Stults; Jeffrey ; et al.	2016-08-04
Amorphous Form Of An Akt Inhibiting Pyrimidinyl-cyclopentane Compound, Compositions And Methods Thereof App 20160152575 - Chakravarty; Paroma ; et al.	2016-06-02
Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof Grant 9,315,471 - Babu , et al. April 19, 2	2016-04-19
Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof Grant 9,290,458 - Chakravarty , et al. March 22, 2	2016-03-22
Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazole-5-yl)-5,6-dihydrobenzo[F]- imidazo [1,2-D][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof Grant 9,266,903 - Stults February 23, 2	2016-02-23
Amorphous Form Of An Akt Inhibiting Pyrimidinyl-cyclopentane Compound, Compositions And Methods Thereof App 20150274677 - Chakravarty; Paroma ; et al.	2015-10-01
Polymorphs Of 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]i- Midazo[1,2-d][1,4]oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide, Methods Of Production, And Pharmaceutical Uses Thereof App 20150166570 - Stults; Jeffrey	2015-06-18
Process Of Making Hydroxylated Cyclopentapyrimidine Compounds And Salts Thereof App 20150099880 - Babu; Srinivasan ; et al.	2015-04-09
Romidepsin Solid Forms And Uses Thereof App 20120190817 - Hanko; Jason ; et al.	2012-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.